Y. Ichikawa et al., ABNORMAL EXPRESSION OF APOPTOSIS-RELATED ANTIGENS, FAS AND BCL-2, ON CIRCULATING T-LYMPHOCYTE SUBSETS IN PRIMARY SJOGRENS-SYNDROME, Clinical and experimental rheumatology, 13(3), 1995, pp. 307-313
Objective. To clarify the pathological role of the apoptosis-related m
olecules expressed on peripheral blood (PB) lymphocyte subsets in prim
ary Sjogren's syndrome (SS). Methods. The levels of apoptosis-regulati
ng proteins, Fas and bcl-2, were determined in the PB lymphocyte subse
ts from 21 patients with SS and 14 healthy controls by 2-color flow cy
tometry. Results. In the PB from SS patients, lymphocytopenia, especia
lly CD4+ cell-lymphocytopenia, was prominent. As observed in previous
studies, the percentages of CD4+ CD45RA + cells were lower in the SS p
atients than in the controls, while activated (DR+) cells were increas
ed in CD4+ cells from the patients. Fas+ cells were also increased in
the patients' CD4+ cells and CD8+ cells, but not in their B cells or n
atural killer cells. Furthermore, we observed several positive correla
tions among the percentages of activated cells (DR+ cells or CD45RA- c
ells) and Fas+ cells recognized in the CD4+ and/or CD8+ cells from the
patients. On the other hand, intra-cellular bcl-2 proteins measured a
s mean fluorescence intensity were significantly diminished in the CD4
+ cells, CD8+ cells, CD19+ cells, CD45RO+ cells and Fas+ cells from 14
SS patients compared with 12 healthy controls. In addition, the numbe
rs and/or percentages of CD4+ cells and Fas+ cells positively correlat
ed with their expression of bcl-2 in SS patients. Conclusion. The abno
rmal balance between Fas and bcl-2 expression detected in the PB lymph
ocyte subsets from SS patients relates, at least partially, to the lym
phocytapenia observed in the patients.